A decade after SARS: strategies for controlling emerging coronaviruses
about
Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak controlFrom SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug designCurrent advancements and potential strategies in the development of MERS-CoV vaccinesMiddle East respiratory syndrome: obstacles and prospects for vaccine developmentGroup Selection and Contribution of Minority Variants during Virus Adaptation Determines Virus Fitness and PhenotypeA camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation propertiesMolecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, MalaysiaModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesExceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.Inhibition of proprotein convertases abrogates processing of the middle eastern respiratory syndrome coronavirus spike protein in infected cells but does not reduce viral infectivity.A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.Bat origin of human coronaviruses.Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS.Ball python nidovirus: a candidate etiologic agent for severe respiratory disease in Python regius.Emergence of infectious malignant thrombocytopenia in Japanese macaques (Macaca fuscata) by SRV-4 after transmission to a novel host.Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesisInflammatory Responses Regulating Alveolar Ion Transport during Pulmonary Infections.The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.Detection of alpha- and betacoronaviruses in rodents from Yunnan, ChinaCoronavirus infection, ER stress, apoptosis and innate immunityTargeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral ActivityThe emergence of the Middle East respiratory syndrome coronavirusScreening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1.The coronavirus nucleocapsid is a multifunctional protein.Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Respiratory viruses and bacteria among pilgrims during the 2013 Hajj.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseVaccines, emerging viruses, and how to avoid disasterReplication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels.Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments.Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM.WU.[Stimulation of the antiviral innate immune response by pyrimidine biosynthesis inhibitors: a surprise of phenotypic screening].Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying EnzymeIdentification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1.Evaluation of candidate vaccine approaches for MERS-CoV.
P2860
Q26796501-9C44A149-DF2D-4C7D-A5A7-6617BCD51BCFQ26992345-5C09849A-6514-48BF-81F0-576405BB747BQ27012578-1D816EF5-BDDB-4702-A873-BC34E67256EDQ27013314-21C0D63C-64EE-45C4-B214-C2114D33C514Q27320149-476FA4B9-91C0-499E-89B0-C26D8FB98CA4Q28354158-FDECED05-16E2-460D-9B06-5D9EC1ABBBE4Q28603737-D1E66B99-107E-40B2-B22F-50ADED36A6E3Q30209342-53EBD169-4F82-44AF-A65D-81E215A09B10Q30362113-58CEDC52-A4CC-4B15-9027-DD4B61D2552DQ30365060-EFB40908-7535-44EE-AB9D-59C7E7903C7CQ30379384-E9BB1ACB-5782-4A3F-ADAB-B942A3A570D1Q30382750-FCD17772-8F6B-4293-86C4-38455E333EAFQ30384772-A70AC789-35A1-4A1D-A691-7BAE25583083Q30849473-22BE80B7-3D15-4311-B359-6FF9E7F5FB8FQ33420922-7154014E-EA92-487C-995C-327F5600D652Q33553636-B843DC5D-4D4B-464A-B71B-7403DD1AD288Q33572332-259B470E-30A4-4483-A23B-715338E818AAQ33602849-8D4060B9-D519-46B1-8985-87163F086CD4Q33733748-961AD7AC-0919-44E8-BCE5-339BB4E060EBQ33767779-E78C98A6-E4DE-4F6B-980A-07E838B64EEBQ33826034-AAC7B5EB-0703-4982-B1F2-857018DA7BABQ33934034-0DBDE04C-E3CD-4906-A150-4B62E5CDC812Q34058365-67B91EB9-53C5-483F-A61B-06E1FC917975Q34059146-013E0758-2844-4CEC-99E2-590A6742F97FQ34102257-F6B4F6D7-40CB-4980-9F90-B30A5B63AE82Q34261999-3E341609-F0CC-49AE-BBBF-D6F16CEB5F9FQ34309830-19E5CE01-09AA-4748-99CE-245639EBB37CQ34426735-E43B2110-A5A5-4125-92A2-0BBF478014CDQ34468689-10934974-5263-4957-8219-45A407D727B1Q34586837-EA2794C9-8312-448C-9249-4BA9CEA97F7EQ34641515-4949B1F4-710A-433C-84BB-BECA65956984Q34663663-7EE4F9FC-9604-47D2-8CED-EBE92E32D05FQ35111000-C94A44E1-3D81-4189-B363-693879120D81Q35159147-A986F498-DF34-4DE7-8088-6FCB5E209CC9Q35487951-227F1D4D-B730-4FFF-8EF7-BE17E90F4D2FQ35488034-DDEE752F-EE4C-429E-9F31-3C0E032323D5Q35556938-88EFD54C-7A0E-4D40-A2A4-4B3E0D58B65DQ35758573-DAB7E815-171A-4FE7-88BF-DA770E397719Q35913855-76B47F76-5066-4397-8EE6-DA6F90D4A4E8Q35917397-9BE4541B-2F9B-45C8-828D-5D380DB22D7D
P2860
A decade after SARS: strategies for controlling emerging coronaviruses
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A decade after SARS: strategies for controlling emerging coronaviruses
@ast
A decade after SARS: strategies for controlling emerging coronaviruses
@en
type
label
A decade after SARS: strategies for controlling emerging coronaviruses
@ast
A decade after SARS: strategies for controlling emerging coronaviruses
@en
prefLabel
A decade after SARS: strategies for controlling emerging coronaviruses
@ast
A decade after SARS: strategies for controlling emerging coronaviruses
@en
P2860
P356
P1476
A decade after SARS: strategies for controlling emerging coronaviruses
@en
P2093
Eric F Donaldson
Rachel L Graham
P2860
P2888
P304
P356
10.1038/NRMICRO3143
P407
P577
2013-12-01T00:00:00Z
P6179
1012569007